What Pfizer can learn in Tennessee when it comes to vaccine rollout
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles. (Jim Weber/Daily Memphian)
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles.
Topics
Clint Hermes Stacey Schultz-Cherry vaccine PfizerJane Roberts
Jane Roberts has reported in Memphis for more than 20 years. As a senior member of The Daily Memphian staff, she was assigned to the medical beat during the COVID-19 pandemic. She also has done in-depth work on other medical issues facing our community, including shortages of specialists in local hospitals. She covered K-12 education here for years and later the region’s transportation sector, including Memphis International Airport and FedEx Corp.
Comments
Want to comment on our stories? If you’re a subscriber, scroll down to the comments. If you’re not a subscriber, only paid subscribers can add their thoughts, so subscribe now. Our commenting policy can be viewed here.